Drug Adherence in Hypertension and Cardiovascular Protection

1 Taxonomy of adherence.- I Measuring drug adherence.- 2 Qualitative assessment of adherence.- 3 Electronic monitoring of drug adherence.- 4 Measurements of drugs in plasma/urine.- 5 Assessing adherence measurement in large databases.- 6 Direct observed treatment in hypertension.- 7 Novel technologies for following drug adherence.- 8 Ethical aspects of measuring adherence II Risk factors for non-adherence.- 9 Determinants and barriers to adherence in CV diseases.- 10 Beliefs and adherence.- III Adherence in hypertension and CV protection.- 11 Impact of drug adherence in clinical trials.- 12 Drug adherence in essential hypertension: impact of drugs.- 13 Persistence in hypertension in general practice.- 14 Drug adherence in resistant hypertension.- 15 Drug adherence with cardiovascular medicines (statins).- 16 Adherence and cardiovascular risk.- IV Interventions to improve drug adherence.- 17 Which interventions are useful?.- 18 Use of fixed-dose combinations in CV diseaseprevention.- 19 Nurse-led intervention in Hypertension.- 20 Role of the Pharmacist in supporting adherence.- 21 Integrated approaches to support adherence.- 22 Use of Apps to improve drug adherence.- V Health care consequences of non-adherence.- 23 Global clinical consequence of poor adherence.- 24 Cost of non-adherence.

Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.

• Farmacologia
• Medicina cardiovascular

drug adherence monitoring;resistant hypertension;clinical trials;healthcare network;cost-effectiveness;dyslipidemia;pharmacotherapy;cardiovascular prevention;metabolic disease;diabetes